Skip to main content

Bitterman Kevin's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Dec 16, 2025

Accession no.
0001104659-25-121740
Filed
Dec 16, 2025
Trade date
Dec 12-16, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 20 non-derivative transactions and 1 derivative transaction. Open-market sales total $16.9M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bitterman KevinCIK 0001591747Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2025Common StockSSaleDisposed−16,403$92.05F1−$1,509,896.15425,633Indirect
Dec 12, 2025Common StockSSaleDisposed−3,852$92.58F3−$356,618.16421,781Indirect
Dec 12, 2025Common StockSSaleDisposed−3,446$93.80F4−$323,234.8418,335Indirect
Dec 12, 2025Common StockSSaleDisposed−8,527$92.05F1−$784,910.35377,022Indirect
Dec 12, 2025Common StockSSaleDisposed−2,005$92.58F3−$185,622.9375,017Indirect
Dec 12, 2025Common StockSSaleDisposed−1,793$93.80F4−$168,183.4373,224Indirect
Dec 12, 2025Common StockSSaleDisposed−6,570$92.05F1−$604,768.544,430Indirect
Dec 12, 2025Common StockSSaleDisposed−1,540$92.58F3−$142,573.242,890Indirect
Dec 12, 2025Common StockSSaleDisposed−1,371$93.80F4−$128,599.841,519Indirect
Dec 15, 2025Common StockSSaleDisposed−28,913$91.18F7−$2,636,287.34389,422Indirect
Dec 15, 2025Common StockSSaleDisposed−3,921$92.01F8−$360,771.21385,501Indirect
Dec 15, 2025Common StockSSaleDisposed−14,811$91.18F7−$1,350,466.98358,413Indirect
Dec 15, 2025Common StockSSaleDisposed−2,049$92.01F8−$188,528.49356,364Indirect
Dec 15, 2025Common StockSSaleDisposed−11,427$91.18F7−$1,041,913.8630,092Indirect
Dec 15, 2025Common StockSSaleDisposed−1,572$92.01F8−$144,639.7228,520Indirect
Dec 15, 2025Common StockMOption exerciseAcquired+7,000$13.50+$94,5007,000Direct
Dec 15, 2025Common StockSSaleDisposed−7,000$91.87F9−$643,0900Direct
Dec 16, 2025Common StockSSaleDisposed−35,898$91.24F10−$3,275,333.52349,603Indirect
Dec 16, 2025Common StockSSaleDisposed−18,666$91.24F10−$1,703,085.84337,698Indirect
Dec 16, 2025Common StockSSaleDisposed−14,359$91.24F10−$1,310,115.1614,161Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2025Common StockMOption exerciseDisposed−7,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.5289 to $92.4325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (7), (8), (9) and (10).

Referenced by the price of 3 transactions in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.52 to $93.3796 inclusive.

Referenced by the price of 3 transactions in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.52 to $94.255 inclusive.

Referenced by the price of 3 transactions in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.99 inclusive.

Referenced by the price of 3 transactions in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.48 inclusive.

Referenced by the price of 3 transactions in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.79 to $91.95 inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.705 inclusive.

Referenced by the price of 3 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)